This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2cxv
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /><applet load="2cxv" size="450" color="white" frame="true" align="right" spinBox="true" caption="2cxv, resolution 1.40Å" /> '''Dual Modes of Modifi...)
Next diff →
Revision as of 07:12, 21 November 2007
|
Dual Modes of Modification of Hepatitis A Virus 3C Protease by a Serine-Derived betaLactone: Selective Crystallization and High-resolution Structure of the His-102 Adduct
Overview
Hepatitis A virus (HAV) 3C proteinase is a member of the picornain, cysteine proteases responsible for the processing of the viral, polyprotein, a function essential for viral maturation and infectivity., This and its structural similarity to other 3C and 3C-like proteases make, it an attractive target for the development of antiviral drugs. Previous, solution NMR studies have shown that a Cys24Ser (C24S) variant of HAV 3C, protein, which displays catalytic properties indistinguishable from the, native enzyme, is irreversibly inactivated by, N-benzyloxycarbonyl-l-serine-beta-lactone (1a) through alkylation of the, sulfur atom at the active site Cys172. However, crystallization of an, enzyme-inhibitor adduct from the reaction mixture followed by X-ray, structural analysis shows only covalent modification of the, epsilon2-nitrogen of the surface His102 by the beta-lactone with no, reaction at Cys172. Re-examination of the heteronuclear multiple quantum, coherence (HMQC) NMR spectra of the enzyme-inhibitor mixture indicates, that dual modes of single covalent modification occur with a >/=3:1 ratio, of S-alkylation of Cys172 to N-alkylation of His102. The latter product, crystallizes readily, probably due to the interaction between the phenyl, ring of the N-benzyloxycarbonyl (N-Cbz) moiety and a hydrophobic pocket of, a neighboring protein molecule in the crystal. Furthermore, significant, structural changes are observed in the active site of the 3C protease, which lead to the formation of a functional catalytic triad with Asp84, accepting one hydrogen bond from His44. Although the 3C protease modified, at Cys172 is catalytically inactive, the singly modified His102, N(epsilon2)-alkylated protein displays a significant level of enzymatic, activity, which can be further modified/inhibited by, N-iodoacetyl-valine-phenylalanine-amide (IVF) (in solution and in crystal), or excessive amount of the same beta-lactone inhibitor (in solution). The, success of soaking IVF into HAV 3C-1a crystals demonstrates the usefulness, of this new crystal form in the study of enzyme-inhibitor interactions in, the proteolytic active site.
About this Structure
2CXV is a Single protein structure of sequence from Hepatitis a virus with BBL as ligand. Active as Picornain 3C, with EC number 3.4.22.28 Full crystallographic information is available from OCA.
Reference
Dual modes of modification of hepatitis A virus 3C protease by a serine-derived beta-lactone: selective crystallization and formation of a functional catalytic triad in the active site., Yin J, Bergmann EM, Cherney MM, Lall MS, Jain RP, Vederas JC, James MN, J Mol Biol. 2005 Dec 9;354(4):854-71. Epub 2005 Oct 14. PMID:16288920
Page seeded by OCA on Wed Nov 21 09:20:03 2007
Categories: Hepatitis a virus | Picornain 3C | Single protein | Bergmann, E.M. | Cherney, M.M. | Jain, R.P. | James, M.N.G. | Lall, M.S. | Vederas, J.C. | Yin, J. | BBL | 3c | Beta-lactone | Cysteine protease | Hepatitis a | Inhibitor | Picornavirus
